Global Normal Saline for Parenteral Use Market Growth 2020-2025

Publisher Name :
Date: 16-Oct-2020
No. of pages: 158

According to this study, over the next five years the Normal Saline for Parenteral Use market will register a 3.3%% CAGR in terms of revenue, the global market size will reach $ 3646.9 million by 2025, from $ 3200.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Normal Saline for Parenteral Use business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Normal Saline for Parenteral Use market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Normal Saline for Parenteral Use, covering the supply chain analysis, impact assessment to the Normal Saline for Parenteral Use market size growth rate in several scenarios, and the measures to be undertaken by Normal Saline for Parenteral Use companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Flexible Bag

- Plastic Bottles

- Glass Bottles

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Intramuscular Injection

- Intravenous Injection

- Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Baxter

- Cisen Pharmaceutical

- Pfizer

- ICU Medical

- Fresenius Kabi

- B. Braun

- CR Double-Cran

- Otsuka

- SSY Group

- Kelun Group

- Denis Chem Lab Limited

- Pharmally International

- Shree Krishnakeshav Laboratories

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Normal Saline for Parenteral Use consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Normal Saline for Parenteral Use market by identifying its various subsegments.

- Focuses on the key global Normal Saline for Parenteral Use manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Normal Saline for Parenteral Use with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Normal Saline for Parenteral Use submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Normal Saline for Parenteral Use Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Normal Saline for Parenteral Use Consumption 2015-2025
2.1.2 Normal Saline for Parenteral Use Consumption CAGR by Region
2.2 Normal Saline for Parenteral Use Segment by Type
2.2.1 Flexible Bag
2.2.2 Plastic Bottles
2.2.3 Glass Bottles
2.3 Normal Saline for Parenteral Use Consumption by Type
2.3.1 Global Normal Saline for Parenteral Use Consumption Market Share by Type (2015-2020)
2.3.2 Global Normal Saline for Parenteral Use Revenue and Market Share by Type (2015-2020)
2.3.3 Global Normal Saline for Parenteral Use Sale Price by Type (2015-2020)
2.4 Normal Saline for Parenteral Use Segment by Application
2.4.1 Intramuscular Injection
2.4.2 Intravenous Injection
2.4.3 Others
2.5 Normal Saline for Parenteral Use Consumption by Application
2.5.1 Global Normal Saline for Parenteral Use Consumption Market Share by Type (2015-2020)
2.5.2 Global Normal Saline for Parenteral Use Value and Market Share by Type (2015-2020)
2.5.3 Global Normal Saline for Parenteral Use Sale Price by Type (2015-2020)

3 Global Normal Saline for Parenteral Use by Company
3.1 Global Normal Saline for Parenteral Use Sales Market Share by Company
3.1.1 Global Normal Saline for Parenteral Use Sales by Company (2018-2020)
3.1.2 Global Normal Saline for Parenteral Use Sales Market Share by Company (2018-2020)
3.2 Global Normal Saline for Parenteral Use Revenue Market Share by Company
3.2.1 Global Normal Saline for Parenteral Use Revenue by Company (2018-2020)
3.2.2 Global Normal Saline for Parenteral Use Revenue Market Share by Company (2018-2020)
3.3 Global Normal Saline for Parenteral Use Sale Price by Company
3.4 Global Normal Saline for Parenteral Use Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Normal Saline for Parenteral Use Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Normal Saline for Parenteral Use Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Normal Saline for Parenteral Use by Regions
4.1 Normal Saline for Parenteral Use by Regions
4.2 Americas Normal Saline for Parenteral Use Consumption Growth
4.3 APAC Normal Saline for Parenteral Use Consumption Growth
4.4 Europe Normal Saline for Parenteral Use Consumption Growth
4.5 Middle East & Africa Normal Saline for Parenteral Use Consumption Growth

5 Americas
5.1 Americas Normal Saline for Parenteral Use Consumption by Countries
5.1.1 Americas Normal Saline for Parenteral Use Consumption by Countries (2015-2020)
5.1.2 Americas Normal Saline for Parenteral Use Value by Countries (2015-2020)
5.2 Americas Normal Saline for Parenteral Use Consumption by Type
5.3 Americas Normal Saline for Parenteral Use Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Normal Saline for Parenteral Use Consumption by Regions
6.1.1 APAC Normal Saline for Parenteral Use Consumption by Regions (2015-2020)
6.1.2 APAC Normal Saline for Parenteral Use Value by Regions (2015-2020)
6.2 APAC Normal Saline for Parenteral Use Consumption by Type
6.3 APAC Normal Saline for Parenteral Use Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Normal Saline for Parenteral Use by Countries
7.1.1 Europe Normal Saline for Parenteral Use Consumption by Countries (2015-2020)
7.1.2 Europe Normal Saline for Parenteral Use Value by Countries (2015-2020)
7.2 Europe Normal Saline for Parenteral Use Consumption by Type
7.3 Europe Normal Saline for Parenteral Use Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Normal Saline for Parenteral Use by Countries
8.1.1 Middle East & Africa Normal Saline for Parenteral Use Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Normal Saline for Parenteral Use Value by Countries (2015-2020)
8.2 Middle East & Africa Normal Saline for Parenteral Use Consumption by Type
8.3 Middle East & Africa Normal Saline for Parenteral Use Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Normal Saline for Parenteral Use Distributors
10.3 Normal Saline for Parenteral Use Customer

11 Global Normal Saline for Parenteral Use Market Forecast
11.1 Global Normal Saline for Parenteral Use Consumption Forecast (2021-2025)
11.2 Global Normal Saline for Parenteral Use Forecast by Regions
11.2.1 Global Normal Saline for Parenteral Use Forecast by Regions (2021-2025)
11.2.2 Global Normal Saline for Parenteral Use Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Normal Saline for Parenteral Use Forecast by Type
11.8 Global Normal Saline for Parenteral Use Forecast by Application

12 Key Players Analysis
12.1 Baxter
12.1.1 Company Information
12.1.2 Normal Saline for Parenteral Use Product Offered
12.1.3 Baxter Normal Saline for Parenteral Use Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Baxter Latest Developments
12.2 Cisen Pharmaceutical
12.2.1 Company Information
12.2.2 Normal Saline for Parenteral Use Product Offered
12.2.3 Cisen Pharmaceutical Normal Saline for Parenteral Use Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Cisen Pharmaceutical Latest Developments
12.3 Pfizer
12.3.1 Company Information
12.3.2 Normal Saline for Parenteral Use Product Offered
12.3.3 Pfizer Normal Saline for Parenteral Use Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Pfizer Latest Developments
12.4 ICU Medical
12.4.1 Company Information
12.4.2 Normal Saline for Parenteral Use Product Offered
12.4.3 ICU Medical Normal Saline for Parenteral Use Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 ICU Medical Latest Developments
12.5 Fresenius Kabi
12.5.1 Company Information
12.5.2 Normal Saline for Parenteral Use Product Offered
12.5.3 Fresenius Kabi Normal Saline for Parenteral Use Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Fresenius Kabi Latest Developments
12.6 B. Braun
12.6.1 Company Information
12.6.2 Normal Saline for Parenteral Use Product Offered
12.6.3 B. Braun Normal Saline for Parenteral Use Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 B. Braun Latest Developments
12.7 CR Double-Cran
12.7.1 Company Information
12.7.2 Normal Saline for Parenteral Use Product Offered
12.7.3 CR Double-Cran Normal Saline for Parenteral Use Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 CR Double-Cran Latest Developments
12.8 Otsuka
12.8.1 Company Information
12.8.2 Normal Saline for Parenteral Use Product Offered
12.8.3 Otsuka Normal Saline for Parenteral Use Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Otsuka Latest Developments
12.9 SSY Group
12.9.1 Company Information
12.9.2 Normal Saline for Parenteral Use Product Offered
12.9.3 SSY Group Normal Saline for Parenteral Use Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 SSY Group Latest Developments
12.10 Kelun Group
12.10.1 Company Information
12.10.2 Normal Saline for Parenteral Use Product Offered
12.10.3 Kelun Group Normal Saline for Parenteral Use Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Kelun Group Latest Developments
12.11 Denis Chem Lab Limited
12.11.1 Company Information
12.11.2 Normal Saline for Parenteral Use Product Offered
12.11.3 Denis Chem Lab Limited Normal Saline for Parenteral Use Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Denis Chem Lab Limited Latest Developments
12.12 Pharmally International
12.12.1 Company Information
12.12.2 Normal Saline for Parenteral Use Product Offered
12.12.3 Pharmally International Normal Saline for Parenteral Use Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Pharmally International Latest Developments
12.13 Shree Krishnakeshav Laboratories
12.13.1 Company Information
12.13.2 Normal Saline for Parenteral Use Product Offered
12.13.3 Shree Krishnakeshav Laboratories Normal Saline for Parenteral Use Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Shree Krishnakeshav Laboratories Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Normal Saline for Parenteral Use Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Flexible Bag
Table 5. Major Players of Plastic Bottles
Table 6. Major Players of Glass Bottles
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Normal Saline for Parenteral Use Consumption Market Share by Type (2015-2020)
Table 9. Global Normal Saline for Parenteral Use Revenue by Type (2015-2020) ($ million)
Table 10. Global Normal Saline for Parenteral Use Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Normal Saline for Parenteral Use Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Normal Saline for Parenteral Use Consumption Market Share by Application (2015-2020)
Table 14. Global Normal Saline for Parenteral Use Value by Application (2015-2020)
Table 15. Global Normal Saline for Parenteral Use Value Market Share by Application (2015-2020)
Table 16. Global Normal Saline for Parenteral Use Sale Price by Application (2015-2020)
Table 17. Global Normal Saline for Parenteral Use Sales by Company (2017-2019) (M Units)
Table 18. Global Normal Saline for Parenteral Use Sales Market Share by Company (2017-2019)
Table 19. Global Normal Saline for Parenteral Use Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Normal Saline for Parenteral Use Revenue Market Share by Company (2017-2019)
Table 21. Global Normal Saline for Parenteral Use Sale Price by Company (2017-2019)
Table 22. Global Normal Saline for Parenteral Use Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Normal Saline for Parenteral Use Products Offered
Table 24. Normal Saline for Parenteral Use Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Normal Saline for Parenteral Use Consumption by Regions 2015-2020 (M Units)
Table 26. Global Normal Saline for Parenteral Use Consumption Market Share by Regions 2015-2020
Table 27. Global Normal Saline for Parenteral Use Value by Regions 2015-2020 ($ Millions)
Table 28. Global Normal Saline for Parenteral Use Value Market Share by Regions 2015-2020
Table 29. Americas Normal Saline for Parenteral Use Consumption by Countries (2015-2020) (M Units)
Table 30. Americas Normal Saline for Parenteral Use Consumption Market Share by Countries (2015-2020)
Table 31. Americas Normal Saline for Parenteral Use Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Normal Saline for Parenteral Use Value Market Share by Countries (2015-2020)
Table 33. Americas Normal Saline for Parenteral Use Consumption by Type (2015-2020) (M Units)
Table 34. Americas Normal Saline for Parenteral Use Consumption Market Share by Type (2015-2020)
Table 35. Americas Normal Saline for Parenteral Use Consumption by Application (2015-2020) (M Units)
Table 36. Americas Normal Saline for Parenteral Use Consumption Market Share by Application (2015-2020)
Table 37. APAC Normal Saline for Parenteral Use Consumption by Countries (2015-2020) (M Units)
Table 38. APAC Normal Saline for Parenteral Use Consumption Market Share by Countries (2015-2020)
Table 39. APAC Normal Saline for Parenteral Use Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Normal Saline for Parenteral Use Value Market Share by Regions (2015-2020)
Table 41. APAC Normal Saline for Parenteral Use Consumption by Type (2015-2020) (M Units)
Table 42. APAC Normal Saline for Parenteral Use Consumption Market Share by Type (2015-2020)
Table 43. APAC Normal Saline for Parenteral Use Consumption by Application (2015-2020) (M Units)
Table 44. APAC Normal Saline for Parenteral Use Consumption Market Share by Application (2015-2020)
Table 45. Europe Normal Saline for Parenteral Use Consumption by Countries (2015-2020) (M Units)
Table 46. Europe Normal Saline for Parenteral Use Consumption Market Share by Countries (2015-2020)
Table 47. Europe Normal Saline for Parenteral Use Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Normal Saline for Parenteral Use Value Market Share by Countries (2015-2020)
Table 49. Europe Normal Saline for Parenteral Use Consumption by Type (2015-2020) (M Units)
Table 50. Europe Normal Saline for Parenteral Use Consumption Market Share by Type (2015-2020)
Table 51. Europe Normal Saline for Parenteral Use Consumption by Application (2015-2020) (M Units)
Table 52. Europe Normal Saline for Parenteral Use Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Normal Saline for Parenteral Use Consumption by Countries (2015-2020) (M Units)
Table 54. Middle East & Africa Normal Saline for Parenteral Use Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Normal Saline for Parenteral Use Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Normal Saline for Parenteral Use Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Normal Saline for Parenteral Use Consumption by Type (2015-2020) (M Units)
Table 58. Middle East & Africa Normal Saline for Parenteral Use Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Normal Saline for Parenteral Use Consumption by Application (2015-2020) (M Units)
Table 60. Middle East & Africa Normal Saline for Parenteral Use Consumption Market Share by Application (2015-2020)
Table 61. Normal Saline for Parenteral Use Distributors List
Table 62. Normal Saline for Parenteral Use Customer List
Table 63. Global Normal Saline for Parenteral Use Consumption Forecast by Countries (2021-2025) (M Units)
Table 64. Global Normal Saline for Parenteral Use Consumption Market Forecast by Regions
Table 65. Global Normal Saline for Parenteral Use Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Normal Saline for Parenteral Use Value Market Share Forecast by Regions
Table 67. Global Normal Saline for Parenteral Use Consumption Forecast by Type (2021-2025) (M Units)
Table 68. Global Normal Saline for Parenteral Use Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Normal Saline for Parenteral Use Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Normal Saline for Parenteral Use Value Market Share Forecast by Type (2021-2025)
Table 71. Global Normal Saline for Parenteral Use Consumption Forecast by Application (2021-2025) (M Units)
Table 72. Global Normal Saline for Parenteral Use Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Normal Saline for Parenteral Use Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Normal Saline for Parenteral Use Value Market Share Forecast by Application (2021-2025)
Table 75. Baxter Product Offered
Table 76. Baxter Normal Saline for Parenteral Use Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 77. Baxter Main Business
Table 78. Baxter Latest Developments
Table 79. Baxter Basic Information, Company Total Revenue (in $ million), Normal Saline for Parenteral Use Manufacturing Base, Sales Area and Its Competitors
Table 80. Cisen Pharmaceutical Product Offered
Table 81. Cisen Pharmaceutical Normal Saline for Parenteral Use Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 82. Cisen Pharmaceutical Main Business
Table 83. Cisen Pharmaceutical Latest Developments
Table 84. Cisen Pharmaceutical Basic Information, Company Total Revenue (in $ million), Normal Saline for Parenteral Use Manufacturing Base, Sales Area and Its Competitors
Table 85. Pfizer Product Offered
Table 86. Pfizer Normal Saline for Parenteral Use Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 87. Pfizer Main Business
Table 88. Pfizer Latest Developments
Table 89. Pfizer Basic Information, Company Total Revenue (in $ million), Normal Saline for Parenteral Use Manufacturing Base, Sales Area and Its Competitors
Table 90. ICU Medical Product Offered
Table 91. ICU Medical Normal Saline for Parenteral Use Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 92. ICU Medical Main Business
Table 93. ICU Medical Latest Developments
Table 94. ICU Medical Basic Information, Company Total Revenue (in $ million), Normal Saline for Parenteral Use Manufacturing Base, Sales Area and Its Competitors
Table 95. Fresenius Kabi Product Offered
Table 96. Fresenius Kabi Normal Saline for Parenteral Use Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 97. Fresenius Kabi Main Business
Table 98. Fresenius Kabi Latest Developments
Table 99. Fresenius Kabi Basic Information, Company Total Revenue (in $ million), Normal Saline for Parenteral Use Manufacturing Base, Sales Area and Its Competitors
Table 100. B. Braun Product Offered
Table 101. B. Braun Normal Saline for Parenteral Use Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 102. B. Braun Main Business
Table 103. B. Braun Latest Developments
Table 104. B. Braun Basic Information, Company Total Revenue (in $ million), Normal Saline for Parenteral Use Manufacturing Base, Sales Area and Its Competitors
Table 105. CR Double-Cran Product Offered
Table 106. CR Double-Cran Basic Information, Company Total Revenue (in $ million), Normal Saline for Parenteral Use Manufacturing Base, Sales Area and Its Competitors
Table 107. CR Double-Cran Main Business
Table 108. CR Double-Cran Latest Developments
Table 109. CR Double-Cran Normal Saline for Parenteral Use Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 110. Otsuka Product Offered
Table 111. Otsuka Normal Saline for Parenteral Use Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 112. Otsuka Main Business
Table 113. Otsuka Latest Developments
Table 114. Otsuka Basic Information, Company Total Revenue (in $ million), Normal Saline for Parenteral Use Manufacturing Base, Sales Area and Its Competitors
Table 115. SSY Group Product Offered
Table 116. SSY Group Normal Saline for Parenteral Use Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 117. SSY Group Main Business
Table 118. SSY Group Latest Developments
Table 119. SSY Group Basic Information, Company Total Revenue (in $ million), Normal Saline for Parenteral Use Manufacturing Base, Sales Area and Its Competitors
Table 120. Kelun Group Product Offered
Table 121. Kelun Group Normal Saline for Parenteral Use Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 122. Kelun Group Main Business
Table 123. Kelun Group Latest Developments
Table 124. Kelun Group Basic Information, Company Total Revenue (in $ million), Normal Saline for Parenteral Use Manufacturing Base, Sales Area and Its Competitors
Table 125. Denis Chem Lab Limited Product Offered
Table 126. Denis Chem Lab Limited Normal Saline for Parenteral Use Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 127. Denis Chem Lab Limited Main Business
Table 128. Denis Chem Lab Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Denis Chem Lab Limited Latest Developments
Table 130. Pharmally International Product Offered
Table 131. Pharmally International Normal Saline for Parenteral Use Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 132. Pharmally International Main Business
Table 133. Pharmally International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Pharmally International Latest Developments
Table 135. Shree Krishnakeshav Laboratories Product Offered
Table 136. Shree Krishnakeshav Laboratories Normal Saline for Parenteral Use Sales (M Units), Revenue ($ Million), Price (US$/K Unit) and Gross Margin (2018-2020E)
Table 137. Shree Krishnakeshav Laboratories Main Business
Table 138. Shree Krishnakeshav Laboratories Latest Developments
Table 139. Shree Krishnakeshav Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Normal Saline for Parenteral Use
Figure 2. Normal Saline for Parenteral Use Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Normal Saline for Parenteral Use Consumption Growth Rate 2015-2025 (M Units)
Figure 5. Global Normal Saline for Parenteral Use Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Flexible Bag
Figure 7. Product Picture of Plastic Bottles
Figure 8. Product Picture of Glass Bottles
Figure 9. Global Normal Saline for Parenteral Use Consumption Market Share by Type (2015-2020)
Figure 10. Global Normal Saline for Parenteral Use Value Market Share by Type (2015-2020)
Figure 11. Normal Saline for Parenteral Use Consumed in Intramuscular Injection
Figure 12. Global Normal Saline for Parenteral Use Market: Intramuscular Injection (2015-2020) (M Units)
Figure 13. Global Normal Saline for Parenteral Use Market: Intramuscular Injection (2015-2020) ($ Millions)
Figure 14. Normal Saline for Parenteral Use Consumed in Intravenous Injection
Figure 15. Global Normal Saline for Parenteral Use Market: Intravenous Injection (2015-2020) (M Units)
Figure 16. Global Normal Saline for Parenteral Use Market: Intravenous Injection (2015-2020) ($ Millions)
Figure 17. Normal Saline for Parenteral Use Consumed in Others
Figure 18. Global Normal Saline for Parenteral Use Market: Others (2015-2020) (M Units)
Figure 19. Global Normal Saline for Parenteral Use Market: Others (2015-2020) ($ Millions)
Figure 20. Global Normal Saline for Parenteral Use Consumption Market Share by Application (2015-2020)
Figure 21. Global Normal Saline for Parenteral Use Value Market Share by Application (2015-2020)
Figure 22. Global Normal Saline for Parenteral Use Sales Market Share by Company in 2017
Figure 23. Global Normal Saline for Parenteral Use Sales Market Share by Company in 2019
Figure 24. Global Normal Saline for Parenteral Use Revenue Market Share by Company in 2017
Figure 25. Global Normal Saline for Parenteral Use Revenue Market Share by Company in 2019
Figure 26. Global Normal Saline for Parenteral Use Sale Price by Company in 2019
Figure 27. Global Normal Saline for Parenteral Use Consumption Market Share by Regions 2015-2020
Figure 28. Global Normal Saline for Parenteral Use Value Market Share by Regions 2015-2020
Figure 29. Americas Normal Saline for Parenteral Use Consumption 2015-2020 (M Units)
Figure 30. Americas Normal Saline for Parenteral Use Value 2015-2020 ($ Millions)
Figure 31. APAC Normal Saline for Parenteral Use Consumption 2015-2020 (M Units)
Figure 32. APAC Normal Saline for Parenteral Use Value 2015-2020 ($ Millions)
Figure 33. Europe Normal Saline for Parenteral Use Consumption 2015-2020 (M Units)
Figure 34. Europe Normal Saline for Parenteral Use Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Normal Saline for Parenteral Use Consumption 2015-2020 (M Units)
Figure 36. Middle East & Africa Normal Saline for Parenteral Use Value 2015-2020 ($ Millions)
Figure 37. Americas Normal Saline for Parenteral Use Consumption Market Share by Countries in 2019
Figure 38. Americas Normal Saline for Parenteral Use Value Market Share by Countries in 2019
Figure 39. Americas Normal Saline for Parenteral Use Consumption Market Share by Type in 2019
Figure 40. Americas Normal Saline for Parenteral Use Consumption Market Share by Application in 2019
Figure 41. United States Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 42. United States Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 44. Canada Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 46. Mexico Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Normal Saline for Parenteral Use Consumption Market Share by Countries in 2019
Figure 48. APAC Normal Saline for Parenteral Use Value Market Share by Regions in 2019
Figure 49. APAC Normal Saline for Parenteral Use Consumption Market Share by Type in 2019
Figure 50. APAC Normal Saline for Parenteral Use Consumption Market Share by Application in 2019
Figure 51. China Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 52. China Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 54. Japan Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 56. Korea Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 58. Southeast Asia Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 59. India Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 60. India Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 62. Australia Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Normal Saline for Parenteral Use Consumption Market Share by Countries in 2019
Figure 64. Europe Normal Saline for Parenteral Use Value Market Share by Countries in 2019
Figure 65. Europe Normal Saline for Parenteral Use Consumption Market Share by Type in 2019
Figure 66. Europe Normal Saline for Parenteral Use Consumption Market Share by Application in 2019
Figure 67. Germany Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 68. Germany Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 69. France Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 70. France Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 71. UK Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 72. UK Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 74. Italy Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 76. Russia Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Normal Saline for Parenteral Use Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Normal Saline for Parenteral Use Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Normal Saline for Parenteral Use Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Normal Saline for Parenteral Use Consumption Market Share by Application in 2019
Figure 81. Egypt Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 82. Egypt Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 84. South Africa Normal Saline for Parenteral Use Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Normal Saline for Parenteral Use Consumption Growth 2015-2020 (M Units)
Figure 86. Israel Normal Saline for Parenteral Use Value Growt
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs